Holistic evaluation of particle formation induced by physical stress in liquid peptide solutions

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Patrick Schlossbauer , Stefanie Schopf , Katrin Lindner, Anna Müller, Ingo Presser, Maximilian Wittmann
{"title":"Holistic evaluation of particle formation induced by physical stress in liquid peptide solutions","authors":"Patrick Schlossbauer ,&nbsp;Stefanie Schopf ,&nbsp;Katrin Lindner,&nbsp;Anna Müller,&nbsp;Ingo Presser,&nbsp;Maximilian Wittmann","doi":"10.1016/j.ejps.2026.107455","DOIUrl":null,"url":null,"abstract":"<div><div>Insufficient physical stability remains a major challenge regarding the development of liquid therapeutics as aggregation and degradation of the drug substance can lead to patient safety concerns through increased immunogenicity or reduced potency. During its lifetime, a drug product (DP) containing for example a therapeutically active peptide can be exposed to various types of physical stress. Here, several methods to induce diverse forms of physical stress on liquid solutions were developed using a buffer solution and implemented by testing different therapeutically active peptides in a tool formulation. Methods to investigate the influence of stress induction during stirring, different kinds of shaking, pumping, and freezing and thawing of the peptide solutions were investigated. The establishment with buffer solution allowed fine-tuning of the parameters to not damage materials like glass vials and tubing themselves. Repeated peristaltic pumping at 110 rpm for 2 h led to time-dependent formation of subvisible particles (SVPs) in each peptide-containing sample. More peptide-specific results were achieved with stirring experiments at 600 rpm over three days. Shaking in glass vials on an orbital shaker at 420 rpm for 10 days did in most cases not introduce enough stress to trigger any response. When switching to a shaking motion induced by a microplate shaker at 1200 rpm, the distinguishability of samples could be increased over the same period due to increased interfacial stress. Freezing and thawing in glass vials at - 50°C led to the formation of SVPs already in peptide-free solutions, possibly due to glass delamination. Subsequent evaluation of visual appearance, absorbance at 620 nm, peptide concentration and covalently bound multimers revealed further insights into stress-induced particle formation of peptide drugs in solution.</div></div>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":"219 ","pages":"Article 107455"},"PeriodicalIF":4.7000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutical Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0928098726000291","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/29 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Insufficient physical stability remains a major challenge regarding the development of liquid therapeutics as aggregation and degradation of the drug substance can lead to patient safety concerns through increased immunogenicity or reduced potency. During its lifetime, a drug product (DP) containing for example a therapeutically active peptide can be exposed to various types of physical stress. Here, several methods to induce diverse forms of physical stress on liquid solutions were developed using a buffer solution and implemented by testing different therapeutically active peptides in a tool formulation. Methods to investigate the influence of stress induction during stirring, different kinds of shaking, pumping, and freezing and thawing of the peptide solutions were investigated. The establishment with buffer solution allowed fine-tuning of the parameters to not damage materials like glass vials and tubing themselves. Repeated peristaltic pumping at 110 rpm for 2 h led to time-dependent formation of subvisible particles (SVPs) in each peptide-containing sample. More peptide-specific results were achieved with stirring experiments at 600 rpm over three days. Shaking in glass vials on an orbital shaker at 420 rpm for 10 days did in most cases not introduce enough stress to trigger any response. When switching to a shaking motion induced by a microplate shaker at 1200 rpm, the distinguishability of samples could be increased over the same period due to increased interfacial stress. Freezing and thawing in glass vials at - 50°C led to the formation of SVPs already in peptide-free solutions, possibly due to glass delamination. Subsequent evaluation of visual appearance, absorbance at 620 nm, peptide concentration and covalently bound multimers revealed further insights into stress-induced particle formation of peptide drugs in solution.

Abstract Image

液体多肽溶液中物理应力诱导颗粒形成的整体评价。
物理稳定性不足仍然是液体疗法发展的主要挑战,因为原料药的聚集和降解可能通过增加免疫原性或降低效力导致患者安全问题。在其生命周期内,含有例如治疗活性肽的药品(DP)可暴露于各种类型的物理应激。在这里,几种方法来诱导不同形式的物理应力在液体溶液中使用缓冲溶液,并通过测试不同的治疗活性肽的工具配方实施。方法考察了多肽溶液在搅拌、不同摇动、泵送、冻融过程中应力诱导的影响。缓冲溶液的建立允许对参数进行微调,以免损坏玻璃小瓶和管本身等材料。以110 rpm重复蠕动泵送2小时,导致每个含肽样品中形成随时间变化的不可见颗粒(svp)。在600转/分的转速下进行三天的搅拌实验,获得了更多的肽特异性结果。在大多数情况下,在轨道振动器上以420转/分的速度摇动玻璃小瓶10天,不会产生足够的应力来触发任何反应。当切换到由微孔板振动筛在1200rpm下引起的振动运动时,由于界面应力的增加,样品的可分辨性可以在相同的时间内增加。在- 50°C的玻璃小瓶中冷冻和解冻导致已经在无肽溶液中形成svp,可能是由于玻璃分层。随后对视觉外观、620nm吸光度、多肽浓度和共价结合多聚体的评价进一步揭示了溶液中应力诱导的多肽药物颗粒形成。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
9.60
自引率
2.20%
发文量
248
审稿时长
50 days
期刊介绍: The journal publishes research articles, review articles and scientific commentaries on all aspects of the pharmaceutical sciences with emphasis on conceptual novelty and scientific quality. The Editors welcome articles in this multidisciplinary field, with a focus on topics relevant for drug discovery and development. More specifically, the Journal publishes reports on medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery (including gene delivery), drug targeting, pharmaceutical technology, pharmaceutical biotechnology and clinical drug evaluation. The journal will typically not give priority to manuscripts focusing primarily on organic synthesis, natural products, adaptation of analytical approaches, or discussions pertaining to drug policy making. Scientific commentaries and review articles are generally by invitation only or by consent of the Editors. Proceedings of scientific meetings may be published as special issues or supplements to the Journal.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书